Biocare Medical Launches Seven Antibody Markers for Clinical Diagnostic and Cancer Research Applications
The launch focuses on several immunooncology markers that are critical for early-stage cancer drug development and patient treatment.
Read MorePosted by | Apr 27, 2020 | Biochemicals & Chemical Reagents, Cancer, Melanoma, Tissue Processing |
The launch focuses on several immunooncology markers that are critical for early-stage cancer drug development and patient treatment.
Read MorePosted by | Apr 21, 2020 | Breast, Cancer, Cervical (HPV), Leukemia, Lung Cancer, Lymphoma, Melanoma, Molecular Diagnostics, Pancreatic, Prostate, Unknown Origin & Other Cancer Types |
The Pathfinder study will enroll 6,200 participants to evaluate Grail’s investigational multicancer early detection test in clinical practice.
Read MorePosted by Steve Halasey | Apr 13, 2020 | Cancer, Molecular Diagnostics, Pancreatic, Specimen Collection & Handling |
Analysis of cell-free DNA in blood samples is revolutionizing cancer treatment and prognosis.
Read MorePosted by | Apr 8, 2020 | Lung Cancer, Urinalysis & Toxicology |
A noninvasive urine test that can detect the presence of proteins linked to lung cancer could help detect more tumors in the early stages of the disease.
Read MorePosted by | Apr 6, 2020 | Molecular Diagnostics |
The agreement will help both companies pursue FDA approval for their diagnostic testing services and specimen collection products.
Read More